alanyl-glutamyl-aspartyl-glycine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buadze, TZh; Dzhokhadze, TA; Gaĭozishvili, MN; Lazhava, TA; Rogava, MA | 1 |
1 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
[Functional regulation of genome with peptide bioregulators by hypertrophic cardiomyopathy (by patients and relatives)].
Topics: Aneuploidy; Cardiomyopathy, Hypertrophic; Chromatin; Chromosome Aberrations; Dipeptides; Female; Genome, Human; Humans; Lymphocytes; Male; Oligopeptides; Peptides; Primary Cell Culture | 2013 |